NOTICE OF INTENT TO AWARD A BRAND NAME ONLY IDIQ:
This notice announces the intent by the U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to procure a Brand Name Only Indefinite Delivery/Indefinite Quantity (IDIQ) as prescribed in FAR 13.501(a)(1)(i). The recommended Original Equipment Manufacturer (OEM) for this brand name requirement is: Getinge USA Sales, LLC; Cage Code 7Z1K6; 45 Barbour Pond Drive, Wayne, NJ 07470. Getinge USA Sales and TrillaMed LLC are authorized licensed resellers of Getinge brand name equipment.
USAMRIID works closely with other U.S. Army Medical Research and Development Command (USAMRDC) organizations, DoD, the Interagency (including Interagency Laboratories), and private companies to accomplish its mission of protecting the Warfighter from biological threats and being prepared to investigate disease outbreaks or threats to public health. All regulated medical waste from laboratories and biocontainment spaces (BSL-3 and BSL-4) must be sterilized prior to disposition IAW AR 385-10, DA Pam 385-69, DoDM 6055.18, and Biosafety in Microbiological and Biomedical Laboratories (BMBL) 6th Edition.
The objectives of this IDIQ are to (1) replace biocontainment sterilizer unit(s) (to include removal and disposal of existing units as well as installation of new units with biocontainment bioseal, certification and validation) and (2) upgrade software operating control systems for existing pass-through biocontainment autoclaves.
The contractor shall provide all personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items and non-personal services necessary to perform biocontainment sterilizer replacement (to include removal and disposal of existing biocontainment sterilizer units as well as installation of new units with biocontainment bioseal, certification and validation), and upgrade of existing biocontainment autoclave controls (MCII, PAC-3000).
Minimum Essential Characteristics for a Steam Sterilizer
- 26''x26''x39'' Chamber
- Single automatic Door (BSL2)
- Double door units (BSL3 and 4)
- With Interior Rack & 2 Shelves
- Exports cycle records to USB storage device
- Shall be a microcomputer-controlled steam sterilizer that offers the option of either prevacuum or gravity displacement cycles for sterilization of laboratory, research, and animal care supplies
- Shall feature an Avanti touch-panel control interface with 19 selectable pre-programmed cycles.
- Shall have the ability for the door to remain sealed during potential utility failure.
Shall have NetCOM enabled Ethernet connection for remote process monitoring; a thermal printer that documents cycle performance, and a user accessible connection for downloading cycle records to a USB flash drive.
- Shall have independently validated bioseal flange (For BSL3 and 4 Units)
- Shall have stainless steel siding enclosing the unit for multiple install method possibilities.
- Contractor shall provide installation of purchased unit and deinstallation of existing unit for Government disposition.
SERVICES requested:
Single mobilization, relating to:
- Supervision of Customer's rigging contractor (at building site)
- Final set-in place
- Equipment leveling
- Equipment assembly
- Identify final utility connection points
- Perform equipment startup
- vendor will provide operator & supervisor training
The North American Industry Classification System (NAICS) for this requirement is 811310 Commercial and Industrial Machinery and Equipment and the PSC Code is 6640 Laboratory Equipment and Supplies.
Proposed solicitation number: HT9425-23-Q-0094
This announcement fulfills the synopsis requirements under FAR 5.102(a)(6) and 5.203(a). This Special Notice of Intent is not a request for competitive quotes. Information received in response to this notice will be considered solely for the purpose of determining whether a brand name competitive procurement is in the best interest of the Government. If no written responses are received by the date listed below, which reflects at least fifteen (15) days after the publication of this notice, the solicitation will be issued as sole source.
All questions and responses concerning this notice shall be emailed to Jeff Flook at jeffrey.l.flook.civ@mail.mil.
Interested concerns must identify their capability in writing to the email address listed above no later than 10:00 AM EST, 20 September 2023.
Background
This notice announces the intent by the U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to procure a Brand Name Only Indefinite Delivery/Indefinite Quantity (IDIQ) as prescribed in 13.501(a)(1)(i). The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) works closely with other U.S. Army Medical Research and Development Command (USAMRDC) organizations, DoD, the Interagency (including Interagency Laboratories), and private companies to accomplish its mission of protecting the Warfighter from biological threats and being prepared to investigate disease outbreaks or threats to public health.
Work Details
The objectives of this IDIQ are to (1) replace biocontainment sterilizer unit(s) (to include removal and disposal of existing units as well as installation of new units with biocontainment bioseal, certification and validation) and (2) upgrade software operating control systems for existing pass-through biocontainment autoclaves. The contractor shall provide all personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items necessary to perform services as described in the PWS and associated contract documents.
Period of Performance
The contract shall be an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a five-year ordering period for the replacement and upgrades of biocontainment sterilizer unit(s).
Place of Performance
The work to be performed under this contract will be performed at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street Bldgs. 1425 and 1412, Fort Detrick, MD 21702
